Article List

WPRIM Management System> DCMS> Cancer Research and Treatment> 2018> 50> 4

Volume: 50 Issue: 4

1. HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma.	Page:1121—1129
2. Beliefs and Intentions to Undergo Lung Cancer Screening among Korean Males.	Page:1096—1105
3. Proposal of a Pretreatment Nomogram for Predicting Local Recurrence after Intensity-Modulated Radiation Therapy in T4 Nasopharyngeal Carcinoma: A Retrospective Review of 415 Chinese Patients.	Page:1084—1095
4. Supporting Low-income Cancer Patients: Recommendations for the Public Financial Aid Program in the Republic of Korea.	Page:1074—1083
5. The Prognostic Significance of Notch1 and Fatty Acid Binding Protein 7 (FABP7) Expression in Resected Tracheobronchial Adenoid Cystic Carcinoma: A Multicenter Retrospective Study.	Page:1064—1073
6. Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study.	Page:1051—1063
7. Delayed Terminal Ileal Perforation in a Relapsed/Refractory B-Cell Lymphoma Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy.	Page:1462—1466
8. Pembrolizumab for Refractory Metastatic Myxofibrosarcoma: A Case Report.	Page:1458—1461
9. Microcystic Stromal Tumor of Testicle: First Case Report and Literature Review.	Page:1452—1457
10. Trends in Gallbladder Cancer Incidence and Survival in Korea.	Page:1444—1451
11. The NEAT Predictive Model for Survival in Patients with Advanced Cancer.	Page:1433—1443
12. Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer.	Page:1418—1432
13. Circular RNA-ZFR Inhibited Cell Proliferation and Promoted Apoptosis in Gastric Cancer by Sponging miR-130a/miR-107 and Modulating PTEN.	Page:1396—1417
14. Projection of Breast Cancer Burden due to Reproductive/Lifestyle Changes in Korean Women (2013-2030) Using an Age-Period-Cohort Model.	Page:1388—1395
15. Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions.	Page:1378—1387
16. Preclinical Study of Novel Curcumin Analogue SSC-5 Using Orthotopic Tumor Xenograft Model for Esophageal Squamous Cell Carcinoma.	Page:1362—1377
17. Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer.	Page:1351—1361
18. Trends in Gastric Cancer Incidence According to the Clinicopathological Characteristics in Korea, 1999-2014.	Page:1343—1350
19. High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In vivo Compared with Monotherapy.	Page:1331—1342
20. Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer.	Page:1324—1330
21. Breast Conservation Therapy Versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23.	Page:1316—1323
22. Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis.	Page:1304—1315
23. The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma.	Page:1294—1303
24. Geographical Variations and Trends in Major Cancer Incidences throughout Korea during 1999-2013.	Page:1281—1293
25. Factors Associated with Prolonged Patient-Attributable Delay in the Diagnosis of Colorectal Cancer.	Page:1270—1280
26. Score for the Survival Probability in Metastasis Breast Cancer: A Nomogram-Based Risk Assessment Model.	Page:1260—1269
27. Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05).	Page:1252—1259
28. Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma.	Page:1238—1251
29. Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.	Page:1226—1237
30. Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy.	Page:1214—1225
31. CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer.	Page:1203—1213
32. Lifestyle Risk Prediction Model for Prostate Cancer in a Korean Population.	Page:1194—1202
33. The Impact of Skin Problems on the Quality of Life in Patients Treated with Anticancer Agents: A Cross-Sectional Study.	Page:1186—1193
34. Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.	Page:1175—1185
35. Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment.	Page:1164—1174
36. Effect of Adjuvant Chemotherapy on Stage II Colon Cancer: Analysis of Korean National Data.	Page:1149—1163
37. A Novel Prognostic Nomogram for Predicting Risks of Distant Failure in Patients with Invasive Breast Cancer Following Postoperative Adjuvant Radiotherapy.	Page:1140—1148
38. Prognostic Factors and Decision Tree for Long-Term Survival in Metastatic Uveal Melanoma.	Page:1130—1139
39. Effect of Smoking Cessation and Reduction on the Risk of Cancer in Korean Men: A Population Based Study.	Page:1114—1120
40. Proximal Resection Margins: More Prognostic than Distal Resection Margins in Patients Undergoing Hilar Cholangiocarcinoma Resection.	Page:1106—1113